ArticleFrontiers in artificial intelligence2026
CNN-RNN framework for lung cancer classification using CT imaging and GAN-based augmentation.
Article in Frontiers in artificial intelligence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lung cancer remains one of the leading causes of cancer-related deaths worldwide, and early identification of malignant abnormalities plays an important role in improving patient survival rates. However, accurate lung cancer classification using CT imaging remains challenging because of limited dataset availability, class imbalance, overlapping lesion characteristics, and lack of interpretability in existing deep learning systems. This study presents a GenAI-driven CNN-RNN framework for explainable lung cancer classification using CT imaging and GAN-based augmentation. The proposed framework integrates convolutional neural networks for spatial feature extraction, LSTM-based recurrent learning for sequential dependency analysis, GAN-assisted augmentation for improving minority class representation, and attention-guided feature fusion for enhanced classification performance. The experimental evaluation was conducted using the publicly available IQ-OTH/NCCD lung cancer CT imaging dataset containing Normal, Benign, and Malignant categories. During preprocessing, normalization, resizing, and image enhancement operations were applied to improve image consistency before training. The framework was trained using the Adam optimizer with 50 epochs and evaluated using 5-fold cross-validation. Experimental results demonstrated that the proposed framework achieved an accuracy of 92.84%, precision of 91.76%, recall of 90.42%, F1-score of 91.08%, and ROC-AUC value of 0.94. Grad-CAM and SHAP visualization methods further improved interpretability by highlighting important lesion regions influencing prediction outcomes. The obtained findings suggest that the proposed CNN-RNN framework can support CT image-based lung cancer classification under limited dataset conditions for CT image-based lung cancer classification under limited medical imaging conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.